Go to main website
Sensus Healthcare - Logo

Press Releases

Sensus Healthcare to Join Russell Microcap® Index

BOCA RATON, Fla., June 25, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before […]
READ MORE

Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit

BOCA RATON, Fla., June 12, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled "New Treatments for Rare/Orphan […]
READ MORE

Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development

New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced the appointment of Dr. Isabelle Raymond, […]
READ MORE

Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth

Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 3, 2018 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
READ MORE

Sensus Healthcare Appoints Rita Gable as Vice President of Sales - Oncology

New Addition to Senior Leadership Team Brings 15 Years of Marketing Experience to Supercharge Sensus' Domestic Oncology Efforts BOCA RATON, Fla., May 1, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today the appointment of […]
READ MORE

Sensus Healthcare to Host First Quarter 2018 Financial Results and Business Update Conference Call on May 3, 2018

BOCA RATON, Fla., April 26, 2018 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, May 3, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]
READ MORE

Get notified about Sensus Healthcare

Get Email Alerts
Sensus Healthcare - Logo - Footer
Sensus Healthcare partners with The Pinnacle Health Group to provide reimbursement support for all customers. Please contact Pinnacle for support by phone at 866-369-9290 or email at [email protected] Hotline consultants are available Monday through Friday from 8:30 AM to 6:00 PM EST.
Contact Us
Sensus Healthcare World Headquarters:

851 Broken Sound Parkway
Boca Raton, FL 33487
[email protected]

Phone 561.922.5808
Toll-free 800.324.9890
Fax 561.948.2071
© Copyright 2023. Sensus Healthcare - All Rights Reserved.